1. ScholarBank@NUS

Chan Wing Yuen,Eli

rp08910

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Chan Wing Yuen,Eli
(not current staff)
Variants
Chan, E.W.Y.
Chan, E.
Chan, E.W.
Chan, W.Y.
 
Main Affiliation
 
Faculty
 
Email
phaelic@nus.edu.sg
 

Publications

Results 41-60 of 88 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
41Sep-2009Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2Zhou, S.-F.; Yang, L.-P.; Zhou, Z.-W.; Liu, Y.-H.; Chan, E. 
421-Dec-2007Is a standard fixed dose of mycophenolate mofetil ideal for all patients?Yau, Wai-Ping ; Vathsala, Anantharaman ; Lou, Huei-Xin; Chan, Eli 
43Jun-1997Lithium pharmacokinetics in Chinese manic-depressive patientsWing, Y.-K.; Chan, E. ; Chan, K.; Lee, S.; Shek, C.C.
44Feb-2012Loading 3-deazaneplanocin A into pegylated unilamellar liposomes by forming transient phenylboronic acid-drug complex and its pharmacokinetic features in Sprague-Dawley ratsSun, F. ; Li, J.; Yu, Q.; Chan, E. 
451-Jun-2009Mechanism-Based Enterohepatic Circulation Model of Mycophenolic Acid and Its Glucuronide Metabolite: Assessment of Impact of Cyclosporine Dose in Asian Renal Transplant PatientsYau, Wai-Ping ; Vathsala, Anantharaman ; Lou, Huei-Xin; Zhou, Shufeng; Chan, Eli 
462005Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugsZhou, S. ; Chan, S.Y. ; Goh, B.C. ; Chan, E. ; Duan, W. ; Huang, M.; McLeod, H.L.
47Jan-2005Multidrug resistance proteins (MRPs) and implication in drug developmentTian, Q. ; Zhang, J.; Chan, E. ; Duan, W.; Zhou, S. 
482005Novel agents that potentially inhibit irinotecan-induced diarrheaYang, X. ; Hu, Z.; Chan, S.Y. ; Chan, E. ; Goh, B.C. ; Duan, W.; Zhou, S. 
49May-2006Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomideYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Duan, W.; Ho, P.C.-L. ; Boelsterli, U.A.; Ng, K.-Y. ; Chan, E. ; Bian, J.-S.; Chen, Y.-Z. ; Huang, M.; Zhou, S.-F. 
50Aug-2006Pharmacokinetics of recombinant human endostatin in ratsYang, X.-X.; Hu, Z.-P.; Chan, E. ; Duan, W.; Zhou, S. 
512001Population pharmacokinetics of carbamazepine in Singapore epileptic patientsChan, E. ; Lee, H.S. ; Hue, S.S.
522001Population pharmacokinetics of carbamazepine in Singapore epileptic patientsChan, E. ; Lee, H.S.; Hue, S.S.
53Aug-1990Population pharmacokinetics of phenytoin in Singapore ChineseChan, E. ; Ti, T.Y.; Lee, H.S.
542004Predicting pharmacokinetic herb-drug interactionsZhou, S. ; Chan, E. ; Li, S.C. ; Huang, M.; Chen, X.; Li, X.; Zhang, Q.; Paxton, J.W.
55Sep-2009Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genesDi, Y.M.; Chan, E. ; Wei, M.Q.; Liu, J.-P.; Zhou, S.-F.
562005Protective effect of Ganoderma (a mushroom with medicinal properties) against various liver injuriesGao, Y.; Gao, H.; Chan, E. ; Tang, W.; Li, X.; Liang, J.; Zhou, S. 
571-Feb-2011Quantification of 3-deazaneplanocin A, a novel epigenetic anticancer agent, in rat biosamples by hydrophilic interaction liquid chromatography-tandem mass spectrometric detectionSun, F. ; Ong, J.C.L.; Yu, Q.; Chan, E. 
58May-2006Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in ChineseZhong, S.-L.; Zhou, S.-F. ; Chen, X.; Chan, S.Y. ; Chan, E. ; Ng, K.-Y. ; Duan, W.; Huang, M.
59Oct-2006Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosusZhong, S.; Huang, M.; Yang, X.; Liang, L.; Wang, Y.; Romkes, M.; Duan, W.; Chan, E. ; Zhou, S.-F. 
60Feb-1994Renal handling of warfarin metabolites in manChan, E. ; McLachlan, A.J.; Rowland, M.